Tango Therapeutics, Inc. (TNGX) has a consensus analyst rating of Buy, based on 10 analysts covering the stock. Of those, 10 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for TNGX is $15.60, representing a -38.4% downside from the current price of $25.33. Price targets range from a low of $12.00 to a high of $19.00.
